Lee Ainslie - Maverick Capital
Holding/activity history for United Therapeutics Corp. (UTHR)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2021 Q4 | 0 | 0 | Sell 100.00% | 0.01 | |
| 2021 Q3 | 4,361 | 0.01 | Reduce 47.79% | 0.01 | $184.59 |
| 2021 Q2 | 8,353 | 0.01 | Add 11.17% | 0.00 | $179.46 |
| 2021 Q1 | 7,514 | 0.01 | Buy | 0.01 | $167.29 |
| 2020 Q1 | 0 | 0 | Sell 100.00% | 0.02 | |
| 2019 Q4 | 14,781 | 0.02 | Add 15.82% | 0.00 | $88.09 |
| 2019 Q3 | 12,762 | 0.01 | Buy | 0.01 | $79.77 |
| 2017 Q3 | 0 | 0 | Sell 100.00% | 0.03 | |
| 2017 Q2 | 18,720 | 0.03 | Reduce 3.70% | 0.00 | $129.75 |
| 2017 Q1 | 19,440 | 0.03 | Reduce 25.83% | 0.01 | $135.39 |
| 2016 Q4 | 26,210 | 0.05 | Add 1.16% | 0.00 | $143.42 |
| 2016 Q3 | 25,910 | 0.04 | Reduce 3.00% | 0.00 | $118.06 |
| 2016 Q2 | 26,710 | 0.04 | Add 27.62% | 0.01 | $105.92 |
| 2016 Q1 | 20,930 | 0.04 | Add 98.01% | 0.02 | $111.42 |
| 2015 Q4 | 10,570 | 0.02 | Add 9.65% | 0.00 | $156.58 |
| 2015 Q3 | 9,640 | 0.02 | Add 155.70% | 0.01 | $131.22 |
| 2015 Q2 | 3,770 | 0.01 | Reduce 16.22% | 0.00 | $174.01 |
| 2015 Q1 | 4,500 | 0.01 | Buy | 0.01 | $172.44 |